Child Neurology Care in Latin America: Challenges and Potential Solutions

Jorge A Vidaurre1, Pedro Weisleder1

  • 1Division of Neurology, Department of Pediatrics, Nationwide Children's Hospital - The Ohio State University, Columbus, Ohio.

Pediatric Neurology
|May 22, 2022
PubMed

Insights

Child neurology in Latin America faces challenges due to underfunding and limited access to resources. Telemedicine and Spanish-language educational initiatives are key to improving care and diagnosis for neurological conditions.

Area of Science:

  • Child Neurology
  • Global Health
  • Latin American Healthcare

Background:

  • Child neurology practice in Latin America is significantly affected by regional sociopolitical instability.
  • The region faces unique challenges impacting pediatric neurological care delivery.

Purpose of the Study:

  • To review the current state of child neurology in Latin America.
  • To identify region-specific conditions and challenges impacting pediatric neurological care.

Main Methods:

  • Literature search focusing on child neurology in Latin America.
  • Analysis of regional health care systems and prevalent conditions.

Main Results:

  • Shortage of child neurologists, particularly in underfunded public hospitals.
  • Language barriers (Spanish) limit access to updated medical knowledge.
  • Fragmented healthcare systems hinder equitable access.
  • Epidemics (Zika, Chikungunya, Dengue) and the COVID-19 pandemic strain resources for chronic neurological conditions.

Conclusions:

  • Virtual platforms (e.g., Zoom) enhance telemedicine and education, especially in Spanish.
  • Collaborative educational efforts are underway.
  • Priorities include improving diagnosis using local resources and enhancing care through telemedicine and education.
Abstract

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
738
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
270
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.8K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
322
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
399
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
283